These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6576383)

  • 1. Experimental studies on the possible combined chemotherapy to neoplasms with Fluosol-DA infusion.
    Ohyanagi H; Nishijima M; Usami M; Nishimatsu S; Matsui E; Saitoh Y
    Prog Clin Biol Res; 1983; 122():315-20. PubMed ID: 6576383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fluosol-DA in extracorporeal circulation - an experimental study (author's transl)].
    Ozono H; Taira A; Toyohira H; Higashi T; Yamashita M; Shimokawa S; Umebayashi Y; Saigenji H; Hamada Y; Arikawa K; Akita H
    Kyobu Geka; 1981 Oct; 34(10):776-80. PubMed ID: 7311221
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possibility of the use of perfluorochemicals (fluorocarbons) as adjuvants in chemotherapy of cancer].
    Kuwamura K; Kokunai T
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1256-61. PubMed ID: 7184453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
    Holden SA; Teicher BA; McIntosh NL; Rose CM
    Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
    Song CW; Lee I; Hasegawa T; Rhee JG; Levitt SH
    Cancer Res; 1987 Jan; 47(2):442-6. PubMed ID: 3098409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA; Holden SA; Jacobs JL
    Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Fluosol-DA on pulmonary vessels.
    Nishimura N; Sugi T; Hiranuma N
    Prog Clin Biol Res; 1983; 122():283-9. PubMed ID: 6878371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluosol-DA as a red-cell substitute in acute anemia.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
    N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygenated fluosol DA-20% distal infusion during coronary angioplasty protects myocardial function.
    Jaffe CC; Wohlgelernter D; Highman HA; Cleman M
    Prog Clin Biol Res; 1986; 211():21-7. PubMed ID: 2938192
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxygenation effect of fluosol-DA on hypoxic tumor tissue and retention of PFCs in the tumor-bearing rats.
    Watanabe M; Okamoto H; Ohyanaqi H; Saitoh Y; Yano K; Tsuda Y; Ueda Y; Yokoyama K
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):547-56. PubMed ID: 3140922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases in brain tumor and cerebral blood flow by blood-perfluorochemical emulsion (Fluosol-DA) exchange.
    Hiraga S; Klubes P; Owens ES; Cysyk RL; Blasberg RG
    Cancer Res; 1987 Jun; 47(12):3296-302. PubMed ID: 3581070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo.
    Kim GE; Song CW
    Cancer Chemother Pharmacol; 1989; 25(2):99-102. PubMed ID: 2513138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental studies on the effect of perfluorochemicals in tumor irradiation].
    Shinoda J; Iwai T; Hattori T; Kondo H; Sakai N; Yamada H
    Gan No Rinsho; 1984 Jan; 30(1):53-8. PubMed ID: 6700116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
    Ishikawa R; Peerless SJ; Hunter IG
    No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
    Teicher BA; Bernal SD; Holden SA; Cathcart KN
    Cancer Chemother Pharmacol; 1988; 21(4):281-5. PubMed ID: 3131032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with Fluosol-DA.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
    Prog Clin Biol Res; 1983; 122():331-42. PubMed ID: 6878375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of perfluorochemicals on BCNU chemotherapy in a rat brain-tumor model].
    Kokunai T; Kuwamura K
    No To Shinkei; 1982 Jun; 34(6):609-15. PubMed ID: 7115598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.
    Teicher BA; Herman TS; Holden SA; Cathcart KN
    Cancer Chemother Pharmacol; 1988; 21(4):286-91. PubMed ID: 3131033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local oxygen supply of the myocardium after extreme hemodilution with Fluosol-DA.
    Kessler M; Vogel H; Günther H; Harrison DK; Höper J
    Prog Clin Biol Res; 1983; 122():237-48. PubMed ID: 6878366
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of a blood substitute (Fluosol-DA, 20%) on cerebral ischemia.
    Oda Y; Handa H; Nagasawa S; Naruo Y; Asato R; Yonekawa Y
    Neurol Res; 1982; 4(1-2):35-45. PubMed ID: 6127644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.